- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03175094
PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to adapt and pilot test the Holistic Health Recovery Program for women with and at risk for HIV (HHRP+), a CDC evidence-based secondary HIV prevention intervention, that will serve as a framework to optimize HIV treatment outcomes and reduce HIV-associated risk for women under correctional community supervision.
Hypotheses
- It will be feasible to recruit and retain HIV+ and at-risk women under community correctional supervision in the pilot study.
- Using the ADAPT-ITT methods, we will be able to adequately adapt HHRP+ for HIV-infected and at-risk women under community supervision.
- The adapted intervention will be feasible to implement and acceptable to participants.
- The adapted intervention will produce higher measureable preliminary effects on HIV-focused treatment outcomes in the intervention group compared with the control group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06106
- Yale AIDS Program
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age ≥18 years old
- female
- have laboratory confirmed HIV OR are at-risk for HIV (ever injected drugs, ever engaged in commercial sex work, were incarcerated in prison or jail within the past 2 years, had condomless sex with an HIV+ partner or partner whose HIV status is unknown in the past 90 days, or had a diagnosed sexually transmitted infection in the past 90 days),
- and are under or anticipating transfer to probation.are either a) sentenced to probation or on intensive pretrial supervision by a probation officer; b) sentenced to parole; or c) incarcerated in jail or prison in the prior 60 days.
Potential participants will be excluded
Exclusion Criteria:
- unable or unwilling to provide informed consent,
- have <3 months of remaining scheduled supervision term,
- or are threatening to staff
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
|
|
Experimental: Holistic Health Recovery Program for HIV+ Intervention
|
Holistic Health Recovery Program for HIV+ (HHRP+) is a CDC-recommended, evidence based behavioral (psychoeducational) group intervention focused on harm reduction principles.
The investigators systematically adapted HHRP+ using findings from qualitative interviews with the target population of adult women living with and at-risk for HIV who are justice-involved (on probation, parole, or recently released from prison or jail).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HIV knowledge from baseline
Time Frame: 3 months
|
HIV knowledge quiz with scores ranging from 0-100, a higher score indicating better knowledge
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Sex-related risk behaviors over time
Time Frame: baseline, 6 months, 12 months
|
NIDA Risk Behavior Assessment (0-18 with higher scores indicating higher risk)
|
baseline, 6 months, 12 months
|
Change in Injection-related risk behaviors over time
Time Frame: baseline, 6 months, 12 months
|
NIDA Risk Behavior Assessment (0-18 with higher scores indicating higher risk)
|
baseline, 6 months, 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jaimie Meyer, M.D., M.S., Yale University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1407014291
- K23DA033858 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
-
National Taiwan UniversityRecruiting
Clinical Trials on Holistic Health Recovery Program for HIV+
-
University of ConnecticutNational Institute on Drug Abuse (NIDA); Yale University; APT Foundation, Inc.CompletedRisk Behavior | HIV | Medication AdherenceUnited States
-
University of ConnecticutCompletedCognitive DysfunctionUnited States
-
Michele StatonNational Institute on Drug Abuse (NIDA)CompletedHepatitis C | Drug Abuse | Acquired Immune Deficiency Syndrome VirusUnited States
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingDisorder; Heart, Functional, Postoperative, Cardiac SurgeryCanada
-
Duke UniversityCompletedStress ReductionUnited States
-
Seoul National University HospitalArmed Forces Capital Hospital, Republic of Korea; Medical Research Collaborating...CompletedLumbar Spinal Stenosis | Spinal Fusion | Lumbar Spondylolisthesis | Enhanced Recovery After SurgeryKorea, Republic of
-
Yale UniversityNational Institute on Drug Abuse (NIDA); University of MalayaCompletedAcquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence
-
Duke UniversityCompletedStress ReductionUnited States
-
Universidad de GranadaCompletedEmotional Stress | Performance AnxietySpain
-
University Health Network, TorontoUnity Health Toronto; Women's College Hospital; MOUNT SINAI HOSPITALCompletedChronic Pain | Sleep | Sleep Disordered BreathingCanada